Chemical Structure : XMU-MP-9
CAS No.: 2251130-41-1
货号: PC-26395Not For Human Use, Lab Use Only.
XMU-MP-9 is bifunctional, specific small molecule K-RAS mutants degrader, facilitates NEDD4-1-mediated ubiquitination and degradation of various oncogenic K-RAS mutants.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥880 | In stock | |
| 50 mg | ¥1280 | In stock | |
| 100 mg | ¥1980 | In stock | |
| 250 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
XMU-MP-9 is bifunctional, specific small molecule K-RAS mutants degrader, facilitates NEDD4-1-mediated ubiquitination and degradation of various oncogenic K-RAS mutants.
XMU-MP-9 could induce decrease of endogenous K-RASG12V protein levels in SW620 cells as early as 12 h treatment and reached a maximum effect at 36 to 48 h.
XMU-MP-9 exhibits potent effect on inhibiting growth of NEDD4-1+/+ SW620 cells in 2-D culture and 3-D soft agar in comparison to NEDD4-1−/− SW620 cells, also induces NEDD4-1-dependent decrease of endogenous K-RASG12V protein levels.
XMU-MP-9 primarily assists NEDD4-1 in attaching ubiquitin to K128 of K-RASG12V.
XMU-MP-9 interacted with both K-RASG12V and NEDD4-1 with similar binding affinities (Kd = 18.4 and 25.4 nM).
XMU-MP-9 promotes ubiquitination and degradation of various K-RAS mutants such as G12D, G12C, G12S, G13V, G13D, and Q61H via lysosomal pathway, but not H-RAS or N-RAS mutants.
XMU-MP-9 inhibits proliferation and anchorage-independent growth of K-RAS mutant harboring cancer cells.
XMU-MP-9 (40 mg/kg once or twice daily via tail vein injection) suppresses tumor development of K-RAS mutant harboring cancer cells in vivo.
| 分子量 | 385.84 | |
| 分子式 | C19H13ClFN3OS | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
N-(2-Chloro-6-fluorobenzyl)-5-(1H-indazol-3-yl)thiophene-3-carboxamide |
|
1. Taoling Zeng, et al. Acta Pharm Sin B. 2026 Feb;16(2):979-993.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright